This site is currently in BETA testing mode.
Send us your feedback!Cure My Disease Weekly
The 10 most notable cure or vaccine studies from the last week.
Lead story
A Phase 3 trial testing the R21 malaria vaccine in 4,800 African children to see if it safely prevents the disease.
Phase 3 trial testing a one-time gene therapy for babies with severe spinal muscular atrophy type 1. Study completed with 33 infants.
Phase 1/2 study testing safety and effectiveness of the Oxford COVID-19 vaccine in 1077 healthy UK volunteers aged 18-55.
A gene editing trial testing a one-time IV treatment for male infants with a rare, life-threatening metabolic disorder called OTC deficiency.
Phase 3 trial testing a one-time gene therapy for babies with severe spinal muscular atrophy type 1. Study measured sitting ability and survival.
Phase 3 trial testing a one-time CRISPR gene therapy for severe sickle cell disease and transfusion-dependent beta-thalassemia.
Study tested a single oral pill for African sleeping sickness. 208 patients received treatment and were followed for 18 months to check if they were cured.